Intravenous Thrombolysis in Ischemic Stroke Patients with Intracranial Neoplasms: Two Cases and a Literature Review

Based on exclusion criteria in the landmark NINDS-rtPA trial, current expert consensus guidelines preclude the use of intravenous recombinant tissue plasminogen activator (IV rtPA) in acute ischemic stroke (AIS) patients with intracranial neoplasm. There are only 3 published cases of administration...

Descripción completa

Detalles Bibliográficos
Autores principales: Neil, William, Ovbiagele, Bruce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189474/
https://www.ncbi.nlm.nih.gov/pubmed/22007235
http://dx.doi.org/10.1155/2011/503758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189474/
https://www.ncbi.nlm.nih.gov/pubmed/22007235
http://dx.doi.org/10.1155/2011/503758

Ejemplares similares